Advancing the next generation of tinnitus treatment.
Building on positive clinical outcomes and patient experiences, in September 2015 we secured significant investment from the international life sciences venture capital fund Fountain Healthcare Partners. This investment will be used to further enhance the scientific and clinical understanding of bi-modal neuromodulation for treating chronic tinnitus, commence US clinical trials and to promote the adoption of mutebutton as a next generation treatment for chronic tinnitus. The ultimate goal is the international launch of the product in 2018.
- An Investigation of Feasibility and Safety of Bi-Modal Stimulation for the Treatment of Tinnitus: An Open-Label Pilot Study C. Hamilton, S. D'Arcy, B. A. Pearlmutter, G. Crispino, E. C. Lalor, B. J. Conlon. Neuromodulation: Technology at the Neural Interface, June 16th 2016.
- Multi-modal Auditory-Somatosensory Neuromodulation for Tinnitus: Patient Suitability Characteristics and Further Studies R. O’Neill, C. Hamilton, B. A. Pearlmutter, G. Crispino, S. D'Arcy, B. Conlon. Proceedings of the Fifty Fifth Annual Meeting of the Irish Otolaryngology Society / Head and Neck Society, October 10-11th 2014.
- Impact of acoustic and tactile multi-modal neuromodulation on objective and subjective measures of tinnitus C. Hamilton, B. Pearlmutter , B. Conlon and G. Crispino. Abstracts of the Fourth Joint Annual Conference, Experimental and Clinical Short Papers Meetings of the British Society of Audiology, International Journal of Audiology 2014; 53: 641–696.
- Impact of acoustic and tactile multi-modal neuromodulation on objective and subjective measures of permanent intractable tinnitus R. O’Neill, C. Hamilton, B. Pearlmutter, G. Crispino, S. Hughes, B. Conlon. Proceedings of the Fifty Fourth Annual Meeting of the Irish Otolaryngology Society / Head and Neck Society, October 10-11th 2013.